نتایج جستجو برای: anti cd20

تعداد نتایج: 365619  

Journal: :Blood 2004
Marijke R Canninga-van Dijk Hanneke M van der Straaten Rob Fijnheer Cornelus J Sanders Jan G van den Tweel Leo F Verdonck

Chronic graft-versus-host disease (cGVHD) is an important determinant of long-term morbidity and mortality in allogeneic stem cell transplantation patients. Because cGVHD has clinical, histologic, and laboratory findings of autoimmune diseases and anti-B-cell therapy has shown efficacy in autoimmune diseases, we hypothesized that monoclonal anti-CD20 antibody therapy might improve patients with...

Journal: :International journal of oncology 2008
Michio Nishida Keisuke Teshigawara Otsura Niwa Sadakazu Usuda Tetsuo Nakamura Peter Ralph Roland Newman Eduardo A Padlan

The anti-CD20 chimeric monoclonal antibody (mAb) rituximab is the most widely used therapeutic antibody for B-cell malignancies. However, approximately 50% of non-Hodgkin's lymphoma (B-NHL) patients respond to treatment with this antibody. Novel humanized antibodies target membrane CD20 with enhanced effector properties should improve treatment for a broader patient population with relapsed and...

Journal: :Human Vaccines & Immunotherapeutics 2018

Journal: :Archives of Pharmacy Practice 2021

Multiple sclerosis is a common leading cause of disability worldwide. CD20-expressing B cells play major role in multiple pathogenesis. Hence, anti-CD20 monoclonal antibodies effectively deplete mainly by complement-dependent cytotoxicity, antibody-dependent cell-mediated phagocytosis, and cellular cytotoxicity. While the precise etiology remains unknown, it now recognized that environment...

Journal: :International immunology 2004
Junji Uchida Youngkyun Lee Minoru Hasegawa Yinghua Liang Alice Bradney Julie A Oliver Kristina Bowen Douglas A Steeber Karen M Haas Jonathan C Poe Thomas F Tedder

CD20 plays a role in human B cell proliferation and is an effective target for immunotherapy. In this study, mouse CD20 expression and biochemistry were assessed for the first time using a new panel of CD20-specific mAb, with CD20 function assessed using CD20-deficient (CD20(-/-)) mice. CD20 expression was B cell restricted and was initiated during late pre-B cell development. The frequency and...

Journal: :Blood 2008
Rosa Lapalombella Bo Yu Georgia Triantafillou Qing Liu Jonathan P Butchar Gerard Lozanski Asha Ramanunni Lisa L Smith William Blum Leslie Andritsos Da-Sheng Wang Amy Lehman Ching-Shih Chen Amy J Johnson Guido Marcucci Robert J Lee L James Lee Susheela Tridandapani Natarajan Muthusamy John C Byrd

Lenalidomide, an immunomodulatory agent that enhances antibody-dependent cellular cytotoxicity (ADCC), is currently being investigated as a therapy for chronic lymphocytic leukemia (CLL). The anti-CD20 antibody rituximab is active in CLL and represents a rational agent to combine with lenalidomide. We therefore examined whether lenalidomide combined with rituximab enhances direct apoptosis and ...

Journal: :Pharmacogenomics and Personalized Medicine 2010

Journal: :Scandinavian Journal of Immunology 2008

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید